石四藥(02005.HK)產品獲批准登記為原料藥

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

石四藥(02005.HK)產品獲批准登記為原料藥

阿思達克 03-20 12:04

石四藥集團(02005.HK)公布，旗下用於與左旋多巴合用治療帕金森病的脫羧(酉每)抑制藥產品「鹽酸芐絲(月井)」，已獲國家藥監局批准，登記成為在上市製劑使用的原料藥。

石四藥集團(02005.HK)

Relevant Stocks

石四藥集團(02005.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

石四藥(02005.HK)產品獲批准登記為原料藥

Services

About Us

Agreement Statement